Aberrant DNA methylation of the p16(INK4a) gene in plasma DNA of breast cancer patients

British Journal of Cancer

Volumn 80, Issue 8, 1999, Pages 1262-1264

  Silva, J M ^a   Dominguez, G ^a   Villanueva, M J ^a   Gonzalez, R ^a   Garcia, J M ^a   Corbacho, C ^a   Provencio, M ^a   Espana P ^a   Bonilla, F ^a,b  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b Clinica del Trabajo   (Spain)

Author keywords

Breast cancer; CpG islands; DNA methylation; p16(INK4a) gene; Plasma DNA

Indexed keywords

DNA; PROTEIN P16;

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CPG ISLAND; DNA METHYLATION; EXON; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BREAST NEOPLASMS; CARCINOMA; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENES, P16; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 0033026117     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690495     Document Type: Article

References (31)

1. Anker P, Stroun M and Maurice PA (1975) Spontaneous release of DNA by human blood lymphocytes in vitro. Cancer Res 35: 2375-2382
2. Anker P, Lefort F, Vasioukhin V, Lyautey J, Lederrey C, Chen XQ, Stroun M, Mulcahy HE and Farthing MJG (1997) K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 112: 1114-1120
3. Bird AP (1986) CpG-rich islands and the function of DNA methylation. Nature 321: 209-213
4. Chen XQ. Stroun M, Magnenat J-L, Nicod LP, Kurt A-M, Lyautey J, Lederrey C and Anker P (1996) Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 2: 1033-1035
5. Foster SA, Wong DJ, Barret MT and Galloway DA (1998) Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol 18: 1793-1801
6. Gardiner-Garden M and Frommer M (1987) CpG islands in vertebrate genomes. J Mol Biol 196: 261-282
7. Goessl C, Heicappell R, Münker R, Anker P, Stroun M, Krause H, Müller M and Miller K (1998) Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma. Cancer Res 58: 4728-4732
8. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM and Jones PA (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55: 4531-4535
9. Herman JG, Latif F, Weng W, Lerman MI, Zhar B, Liu S, Samid D, Duan D-S, Gnarra JR, Linehan WM and Baylin SB (1994) Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91: 9700-9704
10. Herman JG, Merlo A, Mao L, Lapidus RG, Issa J-PJ, Davidson NE, Sidransky D and Baylin SB (1995) Inactivation of the CDKN2/p16/MTSI gene in frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525-4530
11. Hibi K, Robinson R, Booker S, Wu L, Hamilton SR, Sidransky D and Jen J (1998) Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res 58: 1405-1407
12. Issa J-PJ, Ottaviano YL, Celano P, Hamilton SR, Davidson NE and Baylin SB (1994) Methylation of the estrogen receptor CpG island links aging and neoplasia in human colon. Nat Genet 7: 536-540
13. Jones PA and Buckley JD The role of the DNA methylation in cancer. Adv Cancer Res 54: 1-23
14. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stocker E, Day RS III, Johnson BE and Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440
15. Laird PW and Jaenisch R (1994) DNA methylation and cancer. Hum Mol Genet 3: 1487-1495
16. Leon SA, Shapiro B, Sklaroff DM and Yaros MJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37: 646-650
17. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CWG and Wainscoat JS (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350: 485-487
18. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MYS1 in human cancers. Nature Med 1: 686-692
19. Mulcahy HE, Lyautey J, Lederry C, Chen Q-X, Anker P, Alstead EM, Ballinger A, Farthing MJ and Stroun M (1998) A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin Cancer Res 4: 271-275
20. Nawroz H, Koch W, Anker P, Stroun M and Sidransky D (1996) Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 2: 1035-1037
21. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA (1994) Deletions of the cycle-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756
22. INK4a in human cancer. Proc Natl Acad Sci USA 91: 11045-11049
23. Oto M, Miyake S and Yuasa Y (1993) Optimization of nonradioisotopic single strand conformation polymorphism analysis with a conventional minislab gel electrophoresis apparatus. Ann Biochem 213: 19-22
24. Sanchez-Cespedes M, Monzo M, Rosell R, Pifarre A, Calvo R, Lopez-Cabrerizo MP and Astudillo J (1998) Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients. Ann Oncol 9: 113-116
25. Serrano M, Hannon GJ and Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibitions of cyclin D/CDK4. Nature 366: 704-707
26. INK4a. Exp Cell Res 237; 7-13
27. Shapiro B, Chakrabarty M, Cohn EM and Leon SA Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer 51: 2116-2120
28. Singer-Sam J, Yang TP, Mori N, Tanguay RL, Le Bon JM, Flores JC and Riggs AD (1990) DNA methylation in the 5′ region of the mouse PGK-1 gene and a quantitative PCR assay for methylation. In: Nucleic Acid Methylation, Vol. 128, Clawson GA, Willis DB, Weissbach A and Jones PA (eds), pp. 285-289. New York: Alan R. Liss
29. Stroun M, Anker P, Lyautey J, Lederrey C and Maurice PA (1987) Isolation and characterization of DNA from the plasma of cancer patients. Eur J Cancer Clin Oncol 23: 707-712
30. Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C and Beljanski M (1989) Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46: 318-322
31. Vasioukhin V, Anker P, Maurice P, Lyautey J, Lederrey C and Stroun M (1994) Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br J Haematol 86: 774-779